PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $322,000 | -44.1% | 2,761 | +13.1% | 0.11% | -43.2% |
Q1 2015 | $576,000 | -7.5% | 2,441 | -25.8% | 0.19% | +3.3% |
Q4 2014 | $623,000 | +43.5% | 3,291 | +80.9% | 0.18% | +25.2% |
Q3 2014 | $434,000 | +81.6% | 1,819 | -49.7% | 0.15% | +98.6% |
Q2 2014 | $239,000 | +19.5% | 3,619 | +88.1% | 0.07% | +13.8% |
Q1 2014 | $200,000 | – | 1,924 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
Eversept Partners, LP | 58,251 | $491,638 | 0.12% |